Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-24-030627
Filing Date
2024-07-01
Accepted
2024-07-01 16:04:06
Documents
6
Effectiveness Date
2024-07-01

Document Format Files

Seq Description Document Type Size
1 S-8 crdfs-8070124.htm S-8 65977
2 EX-FILING FEES a107ex070124.htm EX-FILING FEES 18961
3 EX-5.1 a51ex070124.htm EX-5.1 12641
4 EX-23.2 a232ex070124.htm EX-23.2 1991
5 image_0.jpg GRAPHIC 195104
6 image_1a.jpg GRAPHIC 280
  Complete submission text file 0001628280-24-030627.txt   369248
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280623 | Film No.: 241090472
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)